The IRE Resource Center is a major research library containing more than 27,000 investigative stories.

Most of our stories are not available for download but can be easily ordered by contacting the Resource Center directly at 573-882-3364 or where a researcher can help you pinpoint what you need.

Search results for "cancer patients" ...

  • CBS News: Healthcare Fraud in America

    For the past four years, CBS News has been committed to investigating healthcare fraud throughout the United States. Our reporting has uncovered schemes preying on veterans, cancer patients, rural communities, and opioid addicts. We’ve been the only network to expose con artists defrauding billions from private insurance companies, Medicare and even Tricare, a component of the military health system. In 2016 we produced an investigative series that found compounding pharmacies were collecting prescriptions for pain creams and billing insurance more than $1 million per week. Last year, our reporting revealed an insurance scheme involving genetic testing that cost the Pentagon trillions. This year’s entries continue our work to expose unscrupulous actors bilking insurance to cash in on the American healthcare system. Our stories go beyond examining the fiscal toll of insurance fraud, they illustrate the human impact these practices have on communities, families, and individuals.
  • Family Conglomerate Runs Suspect Cancer Charities

    How four cancer charities raised tens of millions of dollars from generous Americans and spent only fractions on actual donations to cancer patients. Zero evidence found of listed donations to overseas charities. Traveled to Guatemala to investigate phantom donations listed on charity IRS 990 tax forms.

    The amount of painkillers dispensed in the U.S. nearly quadrupled from 1999-2010 even though the amount of pain Americans have reported has not changed, resulting in what the Centers for Disease Control and prevention calls an epidemic which takes over twenty thousand lives each year. This was an impetus for Reporter Dina Gusovsky to investigate a publicly traded specialty pharmaceutical company called Insys Therapeutics, which is accused of contributing to these grim statistics. It’s main revenue generating drug is a highly addictive opiate one hundred times more powerful that morphine, which the FDA says should only be used for late stage cancer pain; however, the company is now being investigated in at least six states for pushing the drug far beyond cancer patients, engaging in kickback schemes, off-label marketing, and other illegal business practices all in attempt to grow profits. Two days after our report first aired, which included exclusive interviews with whistleblowers and investigators, the company’s CEO resigned.
  • Destroying the Center for Building Hope

    Members of the board of directors of a Sarasota cancer charity went out of their way to hire a businessman with a history of self dealing, bankruptcy and failed business ventures to head up their organization and find novel ways of raising money during the Great Recession. The results were predictable. Carl Ritter put his interests ahead of cancer patients and their families and the Center of Building Hope was forced to shut down three months after Jessica Floum’s initial story.
  • Lawmaker, lobbyist brother stymie oral chemotherapy bill

    The Milwaukee Journal Sentinel discovered that leaders in the Wisconsin Legislature were using a parliamentary trick — a phantom public hearing that was never actually held — to block a vote on an overwhelmingly popular and bipartisan bill aimed at helping cancer patients afford ruinously expensive chemotherapy medications. The articles showed that leaders were not telling the truth when they said they were blocking the bill because the members of their caucuses didn’t support it.
  • "Lifesaving Drugs, Deadly Consequences"

    This investigative piece looks at worker safety issues that affect "the nation's healthcare providers." Health care employees are often put in harms way by handling drugs that are meant to save the "lives of cancer patients," but can be "human carcinogens," too. This report shows that regulation on exposure to these types of drugs in the workplace is weak.
  • Narco Pops Series

    This series shows the rising sales, both legal and illegal, of Actiq, a powerful pain reliever for cancer patients. The series covers many facets of the drug industry. It shows how legal sales of the drug are going up because of shady marketing tactics, as well as how its packaging is misleading and many users do not know about the drug's dangerous side-effects.
  • We Did Nothng Wrong: Why Software Quality Matters

    "Software programs are killing people." At the National Cancer Institute in Panama City, five cancer patients died after an overdose of radiation during their treatments. The U.S.-made software that calculated the dosages of these treatments doubled the dosages during treatment of 27 patients. The International Atomic Energy Agency's investigation of the five deaths blamed radiation poisoning, and said that the remaining patients would be at risk for developing "serious complications" from the radiation. Two of the Panamanian technicians were convicted of second-degree murder and are serving four-year sentences in a Panama prison. And the makers of the software, Multidata Systems International in St. Louis, Missouri, deny any wrongdoing.
  • Hope Sells

    "Starting with casual introductions at public alternative health fairs and culminating inside clinics in Tijuana, PrimeTime followed the process through which a cancer patient can get scammed into paying tens, even hundreds of thousands of dollars for useless, ineffective treatments.." Investigators found United States - based companies that operate illegal clinics in Mexico to offer alternative cancer treatments. Investigators went to the clinics, consulted experts and concluded that they made outrageous claims that could cost cancer patients their lives. The story shut down one clinic.
  • BioPulse Clinic Shut Down

    The story looks into the "medical" practices of BioPulse International, a company that offers alternative treatments to cancer patients in its Tijuana clinic. Reports from respected medical professionals and also from patients that followed the treatments signal that, despite the promises of the BioPulse doctors and the money the patients paid, their condition was unchanged if not worse. A sustained PR campaign (with what now seams misleading information) has also boosted share prices of the company. Following the article Mexican authorities have closed the clinic and the US Federal Trade Commission opened an investigation.